Products for Research Use Only
RegisterLogin

Luvixasertib (CFI-402257)

CAT: 0957-S8257-1gSize: 1 gDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-S8257-1gSize:1 g
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1610759-22-2
Synonyms
Luvixasertib
Target
Serine/threonin kinase
Applications
Cell Cycle
Molecular Formula
C28H30N6O3
Additionnal Information
Luvixasertib (CFI-402257) is an inhibitor of threonine tyrosine kinase (TTK) with IC50 of 1.7 nM and Ki of 0.1 nM, respectively. It is a potential therapeutic for treating hepatocellular carcinoma that works directly by inhibiting cell-cycle checkpoints in cancer cells and indirectly by mobilizing immune cells from the tumor microenvironment.

Related Products

CatalogName
S7552-1gCFI-400945
S7552-01CFI-400945
S7552-25mgCFI-400945
S7552-100mgCFI-400945
S7552-10mM/1mLCFI-400945
S7552-5mgCFI-400945
S0371(1E) -CFI-400437 dihydrochloride
S0371-5mg(1E) -CFI-400437 dihydrochloride
PB9935Anti-Factor I/CFI Antibody Picoband®

Alternative Products

CatalogName
C13298-25mgLuvixasertib (CFI-402257)
A12037-25Luvixasertib (CFI-402257) 25mg
A12037-50Luvixasertib (CFI-402257) 50mg
A12037-5Luvixasertib (CFI-402257) 5mg
A12037-100Luvixasertib (CFI-402257) 100mg
A12037-10Luvixasertib (CFI-402257) 10mg
A12037-1Luvixasertib (CFI-402257) 1mg
BUP03723-01CFI-402257
bs-6548C-01CFI-402257, MPS1/TTK inhibitor
HY-101340-01Luvixasertib

Popular Products